Advanced search
Publication Cover
Acta Orthopaedica Volume 89, 2018 - Issue 1
Journal homepage
2,443
Views
11
CrossRef citations to date
0
Altmetric
Articles

The association between cement type and the subsequent risk of revision surgery in primary total hip replacement

199, 205 hips from the National Joint Registry for England, Wales and Northern Ireland

Lea Trela-LarsenMusculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK;
,
Adrian SayersMusculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK; ;School of Social and Community, Based Medicine, University of Bristol, Bristol, UK; Correspondence[email protected]
,
Ashley William BlomMusculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK; ;Avon Orthopaedic Centre, Southmead Hospital, Bristol, UK
,
Jason Crispin John WebbMusculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK; ;Avon Orthopaedic Centre, Southmead Hospital, Bristol, UK
&
Michael Richard WhitehouseMusculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK; ;Avon Orthopaedic Centre, Southmead Hospital, Bristol, UK
Pages 40-46 | Received 22 Feb 2017, Accepted 16 Sep 2017, Published online: 26 Oct 2017

  • Blom A W, Taylor A H, Pattison G, Whitehouse S, Bannister G C. Infection after total hip arthroplasty: The Avon experience. J Bone Joint Surg Br 2003; 85 (7): 956–9.
  • Browne W J. MCMC Estimation in MLwiN v2.1. Centre for Multilevel Modelling, University of Bristol, 2009.
  • Browne W J, Draper D. A comparison of Bayesian and likelihood-based methods for fitting multilevel models. Bayesian Anal 2006; 1 (3): 473–513.
  • Chiu F Y, Chen C M, Lin C F, Lo W H. Cefuroxime-impregnated cement in primary total knee arthroplasty: A prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002; 84 (5): 759–62.
  • Engesaeter L B, Lie S A, Espehaug B, Furnes O, Vollset S E, Havelin L I. Antibiotic prophylaxis in total hip arthroplasty: Effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74 (6): 644–51.
  • Espehaug B, Furnes O, Havelin L I, Engesaeter L B, Vollset S E. The type of cement and failure of total hip replacements. J Bone Joint Surg Br 2002; 84 (6): 832–8.
  • Greenland S, Poole C. Living with p values: Resurrecting a Bayesian perspective on frequentist statistics. Epidemiology 2013; 24 (1): 62–8.
  • Gundtoft P H, Pedersen A B, Schonheyder H C, Overgaard S. Validation of the diagnosis “prosthetic joint infection”in the Danish Hip Arthroplasty Register. Bone Joint J 2016; 98 (3): 320–25.
  • Havelin L I, Espehaug B, Vollset S E, Engesaeter L B. The effect of the type of cement on early revision of Charnley total hip prostheses: A review of eight thousand five hundred and seventy-nine primary arthroplasties from the Norwegian Arthroplasty Register. J Bone Joint Surg Am 1995; 77 (10): 1543–50.
  • Havelin L I, Engesaeter L B, Espehaug B, Furnes O, Lie S A, Vollset S E. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71 (4): 337–53.
  • Herberts P, Malchau H. Long-term registration has improved the quality of hip replacement: A review of the Swedish THR Register comparing 160,000 cases. Acta Orthop Scand 2000; 71 (2): 111–21.
  • Hickson C J, Metcalfe D, Elgohari S, Oswald T, Masters J P, Rymaszewska M, Reed M R, Sprowson A P. Prophylactic antibiotics in elective hip and knee arthroplasty: An analysis of organisms reported to cause infections and national survey of clinical practice. Bone Joint Res 2015; 4 (11): 181–9.
  • Hinarejos P, Guirro P, Leal J, Montserrat F, Pelfort X, Sorli M L, Horcajada J P, Puig L. The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection: A prospective randomized study in 3000 knees. J Bone Joint Surg Am 2013; 95 (9): 769–74.
  • Hope P G, Kristinsson K G, Norman P, Elson R A. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989; 71 (5): 851–5.
  • Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty: A ten-year survey of 1,688 hips. Clin Orthop Relat Res 1993; (292): 210–14.
  • Josefsson G, Lindberg L, Wiklander B. Systemic antibiotics and gentamicin containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop Relat Res 1981; (159): 194–200.
  • Larson E. Community factors in the development of antibiotic resistance. Annu Rev Public Health 2007; 28: 435–47.
  • Learmonth I D. Total hip replacement and the law of diminishing returns. J Bone Joint Surg Am 2006; 88 (7): 1664–73.
  • Leckie G, Charlton C. runmlwin: A program to run the MLwiN multilevel modeling software from within Stata. J Stat Softw 2013; 52 (11): 1–40.
  • Lindgren J V, Gordon M, Wretenberg P, Karrholm J, Garellick G. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2014 15 (1): 384–9.
  • Makela K T, Matilainen M, Pulkkinen P, Fenstad A M, Havelin L, Engesaeter L, Furnes O, Pedersen A B, Overgaard S, Karrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: Register study of combined Nordic database of four nations. BMJ 2014; 348: f7592.
  • McQueen M, Littlejohn A, Hughes S P. A comparison of systemic cefuroxime and cefuroxime loaded bone cement in the prevention of early infection after total joint replacement. Int Orthop 1987; 11 (3): 241–3.
  • McQueen M M, Hughes S P, May P, Verity L. Cefuroxime in total joint arthroplasty: Intravenous or in bone cement. J Arthroplasty 1990; 5 (2): 169–72.
  • NJR Steering Committee. Bone cement types used in primary hip replacement procedures. 2015a; http://www.njrreports.org.uk/hips-primary-procedures-surgical-technique/H12v1NJR?reportid=363414BB-6BA2-44CF-A764-87E8009E11D9&defaults=DC__Reporting_Period__Date_Range=“2016|NJR2015”,H__JYS__Filter__Calendar_Year__From__ To=“MIN-MAX”,H
  • NJR Steering Committee. National Joint Registry for England, Wales and Northern Ireland: 12th Annual Report. 2015b; http://www.njrcentre.org.uk/njrcentre/Portals/0/Documents/England/Reports/12th%20annual%20 report/NJR%20Online%20Annual%20Report%202015.pdf.
  • NJR Steering Committee. Supporting data quality NJR strategy 2014/16. 2015c; http://www.njrcentre.org.uk/njrcentre/Portals/0/Documents/England/Data quality and strategy/NJR Supporting data quality-strategy 14-16 online.pdf
  • NJR Steering Committee. 2015/16 (FY2014/15) Trust and health board compliance results. 2016; http://www.njrcentre.org.uk/njrcentre/LinkClick.aspx?fileticket =4nVbaVZvCqg%3d&tabid =1435&portalid =0&mid =2539.
  • Parvizi J, Pawasarat I M, Azzam K A, Joshi A, Hansen E N, Bozic K J. Periprosthetic joint infection: The economic impact of methicillin-resistant infections. J Arthroplasty 2010; 25(6Suppl): 103–7.
  • Pfarr B, Burri C. Prospective study on the effect of gentamycin-Palacos in 200 total hip prostheses. Aktuelle Probl Chir Orthop 1979; (12): 207–10.
  • Rasbash J, Charlton C, Browne W J, Healy M, Cameron B. MLwiN Version 2.1. Centre for Multilevel Modelling, University of Bristol, 2009.
  • von Elm E, Altman D G, Egger M, Pocock S J, Gotzsche P C, Vandenbroucke J P, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007; 370 (9596): 1453–7.
  • Wang J, Zhu C, Cheng T, Peng X, Zhang W, Qin H, Zhang X. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013; 8 (12): e82745.
  • Wannske M, Tscherne H. Results of prophylactic use of Refobacin-Palacos in implantation of endoprostheses of the hip joint in Hannover. Aktuelle Probl Chir Orthop 1979; (12): 201–5.
  • WHO. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.2. Geneva: WHO, 2001.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.